Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
An interview with Franco Negron
In this interview, we spoke with Franco Negron, CEO of Simtra, about how the company is advancing its position as a premier CDMO for sterile injectables while preparing for the next wave of complex biologics. read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Eurofins CDMO Alphora Expands High-Potency Development Capacity in Canada
Friday, August 14, 2026
Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient development and manufacturing capabilities in ... read more
Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026
Thursday, August 13, 2026
Axtria Inc. announced plans to expand its Forward Deployed Engineering (FDE) organization to 1,000 engineers by December 2026, creating the industry's... read more
Cycle Selects Forma for U.S. Manufacturing of CML Drug Cavhanza
Wednesday, August 12, 2026
Cycle Pharmaceuticals has selected Forma Life Sciences to establish U.S. commercial manufacturing supply for Cavhanza, an FDA-approved orally ... read more
Aurisco Says Yangzhou Site Passes FDA Inspection for Generic Oligonucleotide API
Wednesday, August 12, 2026
Aurisco Pharmaceutical said its Yangzhou, China manufacturing site has passed an FDA pre-approval inspection for inclisiran sodium, describing the ... read more
GXP-Storage Adds Third UK Facility With Raunds Expansion
Tuesday, August 11, 2026
GXP-Storage is expanding its UK operations with a third restricted-access facility in Raunds, Northamptonshire, adding more than 95,000 cubic feet of ... read more